#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pelizaeus-Merzbacher disease Chronic graft versus host disease in liver Small intestine neuroendocrine tumour Pulmonary tuberculosis Fungal infection Ventricular fibrillation Myeloproliferative neoplasm Primary adrenal insufficiency Ventricular tachycardia Synovial sarcoma Nephrotic syndrome Cluster headache Soft tissue necrosis Ocular lymphoma B-cell small lymphocytic lymphoma recurrent More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Life with Disease Adrenocortical carcinoma Gaucher’s disease type I – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Stevens-Johnson syndrome Leiomyosarcoma recurrent – Trials in Disease Nodal marginal zone B-cell lymphoma – Trials in Disease Familial amyotrophic lateral sclerosis – Treatment Hereditary neuropathic amyloidosis – Trials in Disease Glycogen storage disease type V More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efavirenz Human Serum Albumin Doxycycline Monohydrate Hydroxycarbamide Ponesimod Rifaximin Rbl012.2 Ertugliflozin Bedaquiline Tak-280 SGT-003 Oric-114 Regadenoson Mitomycin LUNRESERTIB PETHIDINE HYDROCHLORIDE A3907 Mexiletine Anhydrous Cholestyramine Lactose Monohydrate More therapies…

    Learn about Your Condition

    Carotid artery occlusion Thalassaemia Hypersensitivity Liposarcoma Oxygen therapy External cephalic version Malformation venous Non-Hodgkin's lymphoma Arterial disorder Hereditary ataxia Measles Premature baby Immune-mediated renal disorder Deep vein thrombosis IgA nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metastatic gastric cancer

  • A study to test the safety and effectiveness of ONA-255 in patients with advanced cancer including breast cancer and gastric cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    • Oesophageal adenocarcinoma
    • Breast cancer
    Spain

  • Study of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Zolbetuximab
    • Capecitabine
    • Docetaxel
    Italy The Netherlands Norway Sweden

  • Evaluating intraperitoneal irinotecan with systemic therapy in patients with gastric peritoneal metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium Czechia France Germany Italy +6

  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    • Gastric cancer
    • Oesophageal cancer metastatic
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
    • Pembrolizumab
    Germany Greece Italy Poland Portugal Romania +1

  • Study on Dostarlimab Immunotherapy for Patients with Localized Gastric Cancer with Deficient Mismatch Repair or High Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Dostarlimab
    France Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!